Cancers 2011, 3(3), 2811-2826; doi:10.3390/cancers3032811
Review

Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer

1,* email, 1email and 1,2email
Received: 23 May 2011; in revised form: 17 June 2011 / Accepted: 21 June 2011 / Published: 27 June 2011
(This article belongs to the Special Issue Exploring Inflammation in Cancers)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The connection between inflammation and tumorigenesis has been well established, based on a great deal of supporting evidence obtained from epidemiological, pharmacological, and genetic studies. One representative example is inflammatory bowel disease, because it is an important risk factor for the development of colon cancer. Moreover, intratumoral infiltration of inflammatory cells suggests the involvement of inflammatory responses also in other forms of sporadic as well as heritable colon cancer. Inflammatory responses and tumorigenesis activate similar sets of transcription factors such as NF-kB, Stat3, and hypoxia inducible factor and eventually enhances the expression of inflammatory cytokines including tumor necrosis factor (TNF) and chemokines. The expression of TNF and chemokines is aberrantly expressed in a mouse model of colitis-associated carcinogenesis as well as in inflammatory bowel disease and colon cancer in humans. Here, after summarizing the presumed actions of TNF and chemokines in tumor biology, we will discuss the potential roles of TNF and chemokines in chronic inflammation-associated colon cancer in mice.
Keywords: cyclooxygenase 2; tumor-associated macrophage; neovascularization; NF-kB; hypoxia inducible factor
PDF Full-text Download PDF Full-Text [512 KB, uploaded 27 June 2011 11:05 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Mukaida, N.; Sasakki, S.-I.; Popivanova, B.K. Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer. Cancers 2011, 3, 2811-2826.

AMA Style

Mukaida N, Sasakki S-I, Popivanova BK. Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer. Cancers. 2011; 3(3):2811-2826.

Chicago/Turabian Style

Mukaida, Naofumi; Sasakki, So-ichiro; Popivanova, Boryana K. 2011. "Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer." Cancers 3, no. 3: 2811-2826.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert